VHL and neoplasm: There is a complex association between mutations in VHL disease and the tumour phenotypes, with type 2 VHL mutations that result in PCCs having only modest (or minimal) effects on HIF dysregulation, while type 1 mutations do not develop PCCs and result in greater HIF stabilisation (Kaelin 2008).